On Sept. 30, 2026, the South China Morning Post reported that for the first time, China’s spending on…
On Sept. 29, 2026, China is offering the world’s brightest young scientists generous 15-year research grants for free…
On Sept. 28, 2026, AN2 Therapeutics, a clinical stage pharmaceutical company focused on the discovery and development of…
On Sept. 25, 2026, the US Food and Drug Administration announced approval of AbbVie’s treatment for Parkinson’s disease…
On Sept. 24, 2026, Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin…
On Sept. 23, 2026, SystImmune announces the U.S. Food and Drug Administration (FDA) has cleared its Investigational New…
On Sept. 23, 2026, research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative…
On Sept. 21, 2026, the U.S. Department of Health and Human Services (HHS) announced a new wave of…
On Sept. 17, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted standard full…
On Sept. 16, 2026, an analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 10, 2026, philanthropist and entrepreneur Tom Golisano announced a $225 million investment in six children’s hospitals,…
On Sept. 10, 2026, Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced plans to further…
On Sept. 9, 2026, the Albert Lasker~DeBakey Clinical Medical Research Award honored three scientists for inventing a bispecific…
On Sept. 8, 2026, Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for the…
On Sept. 8, 2026, Google DeepMind released the AlphaGenome Atlas: a platform containing predictions for the effects of…
On Sept. 8, 2026, researchers from the University of California, Los Angeles (UCLA) announce they have developed a…
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Sept. 3, 2026, Janelia scientists and collaborators announced they have completed a wiring diagram of the central…
On Sept. 1, 2026, Massachusetts Institute of Technology (MIT) researchers release a study that reveals insights into populations…
On Aug. 31, 2026, Eli Lilly and Merida Biosciences, a biotechnology company advancing a new class of precision…
On Aug. 28, 2026, scientists from Gladstone Institutes, UC San Francisco, and Stanford University, in collaboration with Biohub,…
On Aug. 24, 2026, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of IMAAVY®…
On Aug. 20, 2026, Genentech, a member of the Roche Group, announced plans to invest approximately $750 million…
On Aug. 20, 2026, hedge fund billionaire Bill Ackman and his wife, Neri Oxman, announced the were donating…
On Aug. 19, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted accelerated…
On Aug. 17, 2026, Massachusetts Institute of Technology (MIT) researchers announce they have engineered bacteria that can function…
On Aug. 12, 2026, the Medical Research Council (MRC) announced a £20 million investment in a new Pre-clinical…
On Aug. 10, 2026, Jazz Pharmaceuticals and Actio Biosciences announced the companies have entered into a definitive agreement…
On Aug. 10, 2026, Chinese researchers have created an open-source AI system capable of bridging the gap between…